Fengyuan Pharmaceutical Industry's controlling shareholder plans to transfer 5.1% of the shares, which will not affect control rights.

On August 11, 2025, Anhui Fengyuan Pharmaceutical Co., Ltd. announced that its controlling shareholder, Fengyuan Group, and its concerted action person, Ma'anshan Fengyuan, intend to transfer 23,698,554 shares of the company, accounting for 5.10% of the total share capital, to Hainan Guihe Dayi at a transfer price of 6.72 yuan per share, with a total price of 159 million yuan. The funds of the transferee are from their own, and they have committed not to reduce their holdings within 18 months after the transfer. This transaction does not involve a tender offer or related party transaction, will not lead to a change in the control of the company, and will not affect the company's governance and operations. However, the completion of the transaction is subject to the compliance review of the Shenzhen Stock Exchange, and there is uncertainty in its finalization.